Credit Suisse’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $32.1M | Sell |
|
|||||
|
2023
Q4 | $33.8M | Buy |
|
|||||
|
2023
Q3 | $32.3M | Sell |
|
|||||
|
2023
Q2 | $46.4M | Buy |
|
|||||
|
2023
Q1 | $35.8M | Buy |
|
|||||
|
2022
Q4 | $42.6M | Sell |
|
|||||
|
2022
Q3 | $49.5M | Sell |
|
|||||
|
2022
Q2 | $57.7M | Buy |
|
|||||
|
2022
Q1 | $63M | Sell |
|
|||||
|
2021
Q4 | $87.6M | Sell |
|
|||||
|
2021
Q3 | $100M | Buy |
|
|||||
|
2021
Q2 | $154M | Buy |
|
|||||
|
2021
Q1 | $112M | Buy |
|
|||||
|
2020
Q4 | $117M | Buy |
|
|||||
|
2020
Q3 | $2.91M | Sell |
|
|||||
|
2020
Q2 | $2.48M | Buy |
|
|||||
|
2020
Q1 | $723K | Sell |
|
|||||
|
2019
Q4 | $732K | Sell |
|
|||||
|
2019
Q3 | $734K | Buy |
|
|||||
|
2019
Q2 | $854K | Sell |
|
|||||
|
2019
Q1 | $1.06M | Buy |
|
|||||
|
2018
Q4 | $910K | Buy |
|
|||||
|
2018
Q3 | $564K | Buy |
|
|||||
|
2018
Q2 | $181K | Buy |
|